Latest Period
Q2 2026
Security Snapshot
Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK) Institutional Ownership
CUSIP: 86150R107
13F Institutional Holders and Ownership History from Q2 2019 to Q2 2026
Institutions Reporting
195
Shares (Excl. Options)
76,184,399
Price
$32.72
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Symbol
- STOK on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 76,184,399
- Total 13F value
- $2,492,568,229
- Portfolio coverage rank
- 0%
- Share change
- +4,959,331
- Value change
- +$162,346,313
- Number of holders
- 195
- Shares outstanding
- 62,129,292
- SEC-reported price per share
- $29.65
- Insider filing price
- $29.65
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- STOK - Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share is tracked under CUSIP 86150R107.
- 195 institutions reported positions in Q2 2026.
- 11 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 196 to 195 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $2,314,558,249 to $2,492,568,229.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 195 institutions filings for Q2 2026.
Security key
86150R107
Latest holder period
Q2 2026
13F holders
195
13D/G owners
11
CIK / CUSIP context first
Open Q2 2026 holders
STOK full holder history
Stoke Therapeutics, Inc. SEC filings
Stoke Therapeutics, Inc. company facts
Stoke Therapeutics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 86150R107:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
11
Security
STOK
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 9.9% | -0.9% | $208,227,353 | +$22,110,697 | 5,940,866 | +12% | RTW Investments, LP | 31 Mar 2026 |
| FMR LLC | 8.5% | -13% | $166,725,078 | -$9,031,792 | 5,313,100 | -5.1% | FMR LLC | 30 Jun 2026 |
| Redmile Group, LLC | 6.7% | -16% | $145,952,406 | -$7,423,976 | 4,164,120 | -4.8% | Redmile Group, LLC | 31 Mar 2026 |
| Lynx1 Capital Management LP | 6.5% | -20% | $126,725,118 | -$22,758,941 | 4,038,404 | -15% | Lynx1 Capital Management LP | 30 Jun 2026 |
| BlackRock, Inc. | 6.8% | +17% | $87,769,558 | +$14,428,761 | 3,732,540 | +20% | BlackRock, Inc. | 30 Sep 2025 |
| MORGAN STANLEY | 6.5% | $32,588,288 | 3,426,739 | Morgan Stanley | 31 Dec 2024 | |||
| BAKER BROS. ADVISORS LP | 5.8% | $105,906,763 | 3,336,697 | Baker Bros. Advisors LP | 31 Dec 2025 | |||
| TORONTO DOMINION BANK | 4.9% | -10% | $99,576,836 | 3,173,258 | 0% | The Toronto-Dominion Bank | 30 Jun 2026 | |
| WELLINGTON MANAGEMENT GROUP LLP | 5.2% | $108,504,285 | 3,095,700 | Wellington Management Group LLP | 31 Mar 2026 | |||
| BlackRock Portfolio Management LLC | 4.7% | -8% | $28,946,115 | -$2,192,358 | 2,550,341 | -7% | BlackRock Portfolio Management LLC | 30 Jun 2025 |
| Skorpios Trust | 4.1% | -32% | $29,037,049 | -$12,870,000 | 2,256,181 | -31% | Montrago Trustees Ltd | 22 Aug 2025 |
As of 30 Jun 2026, 195 institutional investors reported holding 76,184,399 shares of Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK). This represents 123% of the company’s total 62,129,292 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
103%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 9.5% | 5,877,357 | +9.1% | 0% | $192,307,120 |
| RTW INVESTMENTS, LP | 9.1% | 5,623,525 | 0% | 1.6% | $184,001,738 |
| FMR LLC | 8.6% | 5,313,100 | -1.3% | 0.01% | $173,844,632 |
| Lynx1 Capital Management LP | 6.5% | 4,038,404 | -15% | 15% | $132,136,579 |
| Redmile Group, LLC | 6.4% | 3,945,920 | -5.2% | 8.7% | $129,110,502 |
| WELLINGTON MANAGEMENT GROUP LLP | 5.7% | 3,519,301 | +14% | 0.02% | $115,151,528 |
| MORGAN STANLEY | 5.6% | 3,452,795 | +0.86% | 0.01% | $112,975,453 |
| BAKER BROS. ADVISORS LP | 5.4% | 3,336,697 | 0% | 0.55% | $109,176,726 |
| TORONTO DOMINION BANK | 5.1% | 3,173,258 | 0% | 0.17% | $103,829,002 |
| STATE STREET CORP | 4.6% | 2,852,240 | +25% | 0% | $93,325,293 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 4.3% | 2,661,739 | +38% | 0.01% | $87,093,000 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.2% | 2,586,937 | +9.8% | 0% | $84,644,579 |
| BVF INC/IL | 4.1% | 2,547,557 | 0% | 2.1% | $83,356,065 |
| T. Rowe Price Investment Management, Inc. | 3.9% | 2,415,139 | +863% | 0.05% | $79,024,000 |
| Siren, L.L.C. | 3.2% | 1,995,347 | 0% | 1.3% | $65,287,754 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 2.9% | 1,823,500 | 0% | 0.62% | $59,664,920 |
| Jupiter Topco LLC | 2.9% | 1,814,408 | 0% | 0.02% | $59,358,358 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.5% | 1,524,309 | +15% | 0% | $49,884,057 |
| Assenagon Asset Management S.A. | 1.8% | 1,128,388 | +24% | 0.05% | $36,920,855 |
| DIMENSIONAL FUND ADVISORS LP | 1.6% | 1,013,911 | +2.4% | 0.01% | $33,173,608 |
| Polar Capital Holdings Plc | 1.3% | 833,716 | -26% | 0.08% | $27,279,188 |
| EcoR1 Capital, LLC | 1.2% | 735,000 | +635% | 1.2% | $24,049,200 |
| MPM BIOIMPACT LLC | 1.2% | 723,314 | -5.7% | 1.4% | $23,666,834 |
| Opaleye Management Inc. | 1.1% | 700,000 | 0% | 2.1% | $22,904,000 |
| GOLDMAN SACHS GROUP INC | 0.93% | 575,344 | -31% | 0% | $18,825,256 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
29
Latest
Q2 2026
Rows shown
1-25 of 29
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 76,184,399 | $2,492,568,229 | +$162,346,313 | $32.72 | 195 |
| 2026 Q1 | 71,106,237 | $2,314,558,249 | +$130,895,726 | $32.56 | 196 |
| 2025 Q4 | 66,984,195 | $2,126,072,755 | +$58,211,085 | $31.74 | 183 |
| 2025 Q3 | 67,691,438 | $1,574,062,054 | +$64,324,837 | $23.50 | 151 |
| 2025 Q2 | 65,548,147 | $743,993,162 | +$30,166,679 | $11.35 | 133 |
| 2025 Q1 | 63,384,229 | $421,575,155 | +$30,343,505 | $6.65 | 124 |
| 2024 Q4 | 58,062,255 | $640,428,361 | -$5,638,079 | $11.03 | 129 |
| 2024 Q3 | 58,214,468 | $715,466,637 | -$45,762,031 | $12.29 | 116 |
| 2024 Q2 | 61,301,002 | $828,175,296 | +$96,412,204 | $13.51 | 114 |
| 2024 Q1 | 54,138,461 | $730,867,238 | +$123,726,512 | $13.50 | 101 |
| 2023 Q4 | 45,032,645 | $236,869,874 | +$6,784,370 | $5.26 | 81 |
| 2023 Q3 | 43,943,299 | $173,133,829 | -$18,481,683 | $3.94 | 96 |
| 2023 Q2 | 46,534,137 | $494,657,865 | +$21,008,744 | $10.63 | 98 |
| 2023 Q1 | 44,636,031 | $371,816,808 | +$35,289,257 | $8.33 | 97 |
| 2022 Q4 | 40,284,847 | $371,831,189 | -$22,554,117 | $9.23 | 106 |
| 2022 Q3 | 42,272,703 | $544,351,939 | -$11,748,534 | $12.84 | 99 |
| 2022 Q2 | 43,072,954 | $569,403,611 | +$19,595,358 | $13.21 | 88 |
| 2022 Q1 | 41,334,322 | $870,301,369 | +$123,934,287 | $21.05 | 96 |
| 2021 Q4 | 35,383,061 | $848,561,802 | +$26,332,046 | $23.99 | 91 |
| 2021 Q3 | 19,355,184 | $492,398,465 | -$30,803,526 | $25.44 | 89 |
| 2021 Q2 | 20,216,239 | $680,314,450 | -$703,085,149 | $33.66 | 96 |
| 2021 Q1 | 38,422,385 | $1,492,282,987 | -$15,747,693 | $38.84 | 104 |
| 2020 Q4 | 38,644,696 | $2,393,196,414 | +$252,468,837 | $61.93 | 93 |
| 2020 Q3 | 34,632,372 | $1,159,842,494 | +$2,937,942 | $33.49 | 89 |
| 2020 Q2 | 34,945,268 | $824,517,432 | +$9,797,711 | $23.83 | 70 |